Second Circuit Holds that Criminal Penalties for Pharmaceutical Sales Representative’s Off-Label Promotion Violate the First Amendment

by Orrick, Herrington & Sutcliffe LLP

[author: Robin Linsenmayer]

On December 3, 2012, the United States Court of Appeals for the Second Circuit issued an opinion that stands to transform the regulatory landscape in which pharmaceutical and medical device companies operate.  In recent years, the government has initiated a multitude of criminal investigations – often resulting in convictions – based on the alleged off-label promotion of drugs and medical devices by manufacturers and their sales representatives, in violation of the Federal Food, Drug and Cosmetic Act (“FDCA”).  In a decision that calls the government’s initiative into question, a split panel of the Second Circuit vacated the conviction of a sales representative at Jazz Pharmaceuticals, Alfred Caronia, on the ground that Caronia’s off-label promotion of the drug Xyrem constituted speech protected by the First Amendment. 

The Second Circuit Opinion

The opinion, titled United States v. Alfred Caronia, rests primarily on the Court’s conclusion that criminalizing Caronia’s off-label promotion of Xyrem did not withstand the heightened constitutional scrutiny applicable to government restrictions on speech.  The Court found that the prohibition on truthful off-label promotional speech did not reduce patient exposure to unsafe or ineffective drugs, nor did it otherwise further the government’s interest in drug safety and health.  Instead, the Court determined, restrictions on off-label promotion could be expected to “interfere[] with the ability of physicians and patients to receive potentially relevant treatment information,” and that “such barriers to information about off-label use could inhibit, to the public’s detriment, informed and intelligent treatment decisions.” 

To support its conclusions, the Court cited, among other things, the Food and Drug Administration’s (“FDA”) “safe harbor” provision, permitting drug manufacturers to disseminate off-label information through scientific journals.  Implicit in the safe harbor provision, the Court found, is the FDA’s recognition that “‘public health can be served when health care professionals receive truthful and non-misleading scientific and medical information on unapproved uses’ of approved drugs.”

Because restrictions on off-label promotion did not further any articulated government interest, the Court found the prosecution to violate Caronia’s First Amendment rights, and held that “the government cannot prosecute manufacturers and their representatives under the FDCA for speech promoting the lawful, off-label use of an FDA-approved drug.”

Impact for Manufacturers and Sales Representatives

The Second Circuit’s opinion is poised to significantly change the landscape for companies and individuals involved in the promotion of pharmaceuticals and medical devices.  If upheld through the appellate process, the decision will have a profound impact on current government investigations and prosecutions for off-label promotion, and may lead to significant revisions in corporate compliance programs.

However, notwithstanding this favorable decision, manufacturers and sales representatives should not jump just yet to revise policies governing off-label promotional activities.  The case will most likely face a lengthy appellate process, and the decision may not be final for quite some time.  The panel’s decision was met with a strong dissent from Judge Livingston, and it is impossible to predict how the opinion will fare after the appellate process is complete.  Furthermore, the decision is limited to the Second Circuit, and it remains unclear whether other circuits will follow.  In the meantime, manufacturers may remain cautiously optimistic that change is afoot.

The text of the opinion, United States v. Caronia, No. 09-5006-cr, 2012 WL 5992141, -- F.3d -- (2d Cir. Dec. 3, 2012), can be found here.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Orrick, Herrington & Sutcliffe LLP | Attorney Advertising

Written by:

Orrick, Herrington & Sutcliffe LLP

Orrick, Herrington & Sutcliffe LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.